PL1718337T3 - Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilem - Google Patents
Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilemInfo
- Publication number
- PL1718337T3 PL1718337T3 PL05702484T PL05702484T PL1718337T3 PL 1718337 T3 PL1718337 T3 PL 1718337T3 PL 05702484 T PL05702484 T PL 05702484T PL 05702484 T PL05702484 T PL 05702484T PL 1718337 T3 PL1718337 T3 PL 1718337T3
- Authority
- PL
- Poland
- Prior art keywords
- dexecadotril
- racecadotril
- receptor antagonist
- new combinations
- combinations
- Prior art date
Links
- ODUOJXZPIYUATO-UHFFFAOYSA-N 2-[[2-[(acetylthio)methyl]-1-oxo-3-phenylpropyl]amino]acetic acid (phenylmethyl) ester Chemical compound C=1C=CC=CC=1COC(=O)CNC(=O)C(CSC(=O)C)CC1=CC=CC=C1 ODUOJXZPIYUATO-UHFFFAOYSA-N 0.000 title 1
- 229940113081 5 Hydroxytryptamine 3 receptor antagonist Drugs 0.000 title 1
- ODUOJXZPIYUATO-IBGZPJMESA-N benzyl 2-[[(2r)-2-(acetylsulfanylmethyl)-3-phenylpropanoyl]amino]acetate Chemical compound C([C@@H](CSC(=O)C)C(=O)NCC(=O)OCC=1C=CC=CC=1)C1=CC=CC=C1 ODUOJXZPIYUATO-IBGZPJMESA-N 0.000 title 1
- 108700010883 dexecadotril Proteins 0.000 title 1
- 229950008996 dexecadotril Drugs 0.000 title 1
- 108700040249 racecadotril Proteins 0.000 title 1
- 229960002281 racecadotril Drugs 0.000 title 1
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 title 1
- 206010012735 Diarrhoea Diseases 0.000 abstract 1
- 229940122586 Enkephalinase inhibitor Drugs 0.000 abstract 1
- 208000005577 Gastroenteritis Diseases 0.000 abstract 1
- 239000002111 antiemetic agent Substances 0.000 abstract 1
- 229940125683 antiemetic agent Drugs 0.000 abstract 1
- 239000002792 enkephalinase inhibitor Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04290384A EP1563848A1 (en) | 2004-02-12 | 2004-02-12 | New combinations of an anti-emetic agent and an enkephalinase inhibitor |
| PCT/IB2005/000351 WO2005079850A1 (en) | 2004-02-12 | 2005-02-14 | New combinations of an anti emetic agent and an enkephalinase inhibitor |
| EP05702484A EP1718337B1 (en) | 2004-02-12 | 2005-02-14 | New combinations of a 5-ht3 receptor antagonist with racecadotril or dexecadotril |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1718337T3 true PL1718337T3 (pl) | 2010-09-30 |
Family
ID=34684783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05702484T PL1718337T3 (pl) | 2004-02-12 | 2005-02-14 | Nowe kombinacje antagonisty receptora 5-HT3 z recekadotrilem lub deksekadotrilem |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US8222294B2 (pl) |
| EP (2) | EP1563848A1 (pl) |
| JP (1) | JP4987487B2 (pl) |
| KR (1) | KR101152308B1 (pl) |
| CN (1) | CN1917903B (pl) |
| AT (1) | ATE468138T1 (pl) |
| AU (1) | AU2005215262B2 (pl) |
| BR (1) | BRPI0506631B8 (pl) |
| CA (1) | CA2553827C (pl) |
| CY (1) | CY1110202T1 (pl) |
| DE (1) | DE602005021317D1 (pl) |
| DK (1) | DK1718337T3 (pl) |
| EA (1) | EA010625B1 (pl) |
| EC (1) | ECSP066758A (pl) |
| ES (1) | ES2344909T3 (pl) |
| HR (1) | HRP20100363T1 (pl) |
| MA (1) | MA28354A1 (pl) |
| ME (1) | ME01175B (pl) |
| NO (1) | NO337320B1 (pl) |
| NZ (1) | NZ548635A (pl) |
| PL (1) | PL1718337T3 (pl) |
| PT (1) | PT1718337E (pl) |
| RS (1) | RS51329B (pl) |
| SI (1) | SI1718337T1 (pl) |
| TN (1) | TNSN06246A1 (pl) |
| UA (1) | UA88156C2 (pl) |
| WO (1) | WO2005079850A1 (pl) |
| ZA (1) | ZA200605872B (pl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2900823B1 (fr) * | 2006-05-15 | 2009-02-13 | Bioprojet Soc Civ Ile | Nouvelle forme d'administration du racecadotril. |
| EP2462922A1 (en) * | 2010-12-10 | 2012-06-13 | Bioprojet | New form of administration of enkephalinase inhibitor |
| EP2866802B1 (en) * | 2012-06-28 | 2016-07-27 | Johnson & Johnson Consumer Inc. | Racecadotril liquid compositions |
| US9801819B2 (en) * | 2012-06-28 | 2017-10-31 | Johnson & Johnson Consumer Inc. | Racecadotril compositions |
| RU2632441C2 (ru) | 2012-06-28 | 2017-10-04 | МакНЕЙЛ-ППС, ИНК. | Липидные композиции рацекадотрила |
| US9114171B2 (en) * | 2012-06-28 | 2015-08-25 | Mcneil-Ppc, Inc. | Racecadotril liquid compositions |
| MA40859A (fr) | 2014-10-29 | 2017-09-05 | Johnson & Johnson Consumer Inc | Particules de cadotril |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0028575D0 (en) * | 2000-11-23 | 2001-01-10 | Elan Corp Plc | Oral pharmaceutical compositions containing cyclodextrins |
-
2004
- 2004-02-12 EP EP04290384A patent/EP1563848A1/en not_active Withdrawn
-
2005
- 2005-02-14 CN CN2005800046292A patent/CN1917903B/zh not_active Expired - Fee Related
- 2005-02-14 ME MEP-2010-168A patent/ME01175B/me unknown
- 2005-02-14 UA UAA200608901A patent/UA88156C2/ru unknown
- 2005-02-14 EP EP05702484A patent/EP1718337B1/en not_active Expired - Lifetime
- 2005-02-14 WO PCT/IB2005/000351 patent/WO2005079850A1/en not_active Ceased
- 2005-02-14 DK DK05702484.6T patent/DK1718337T3/da active
- 2005-02-14 DE DE602005021317T patent/DE602005021317D1/de not_active Expired - Lifetime
- 2005-02-14 HR HR20100363T patent/HRP20100363T1/hr unknown
- 2005-02-14 EA EA200601466A patent/EA010625B1/ru not_active IP Right Cessation
- 2005-02-14 PL PL05702484T patent/PL1718337T3/pl unknown
- 2005-02-14 AT AT05702484T patent/ATE468138T1/de active
- 2005-02-14 JP JP2006552718A patent/JP4987487B2/ja not_active Expired - Fee Related
- 2005-02-14 SI SI200531056T patent/SI1718337T1/sl unknown
- 2005-02-14 AU AU2005215262A patent/AU2005215262B2/en not_active Ceased
- 2005-02-14 US US10/587,899 patent/US8222294B2/en not_active Expired - Fee Related
- 2005-02-14 NZ NZ548635A patent/NZ548635A/en not_active IP Right Cessation
- 2005-02-14 BR BRPI0506631A patent/BRPI0506631B8/pt not_active IP Right Cessation
- 2005-02-14 ES ES05702484T patent/ES2344909T3/es not_active Expired - Lifetime
- 2005-02-14 KR KR1020067016159A patent/KR101152308B1/ko not_active Expired - Fee Related
- 2005-02-14 CA CA2553827A patent/CA2553827C/en not_active Expired - Fee Related
- 2005-02-14 PT PT05702484T patent/PT1718337E/pt unknown
- 2005-02-14 RS RSP-2010/0286A patent/RS51329B/sr unknown
-
2006
- 2006-07-17 ZA ZA2006/05872A patent/ZA200605872B/en unknown
- 2006-08-03 TN TNP2006000246A patent/TNSN06246A1/fr unknown
- 2006-08-08 EC EC2006006758A patent/ECSP066758A/es unknown
- 2006-08-10 MA MA29256A patent/MA28354A1/fr unknown
- 2006-09-05 NO NO20063973A patent/NO337320B1/no not_active IP Right Cessation
-
2010
- 2010-07-09 CY CY20101100645T patent/CY1110202T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE479687T1 (de) | Kinaseinhibitoren | |
| DK1836201T4 (da) | Pyrrolidininhibitorer af IAP. | |
| MY146989A (en) | Kinase inhibitors | |
| GB2453058A (en) | Kinase antagonists | |
| SI2260875T1 (sl) | Na folatni receptor usmerjena sredstva za slikanje | |
| MX2009005217A (es) | Compuestos heterociclicos que contienen nitrogeno y metodos de uso de los mismos. | |
| MX2009002959A (es) | Composicion de cementacion que comprende dentro cemento sin reaccionar. | |
| WO2005087724A3 (en) | Sulphonylpyrroles as hdac inhibitors | |
| CY1110202T1 (el) | Νεοι συνδυασμοι ενος αντι εμετικου παραγοντα και ενος αναστολεα της εγκεφαλινασης | |
| MX2009004269A (es) | Inhibidores de cinasa mapk/erk. | |
| NO20070211L (no) | Kationiske polymerer som inneholder 2-hydroksyetyl-metakrylsyre som akseleratorer for ASA-liming | |
| ATE423765T1 (de) | Ep2-rezeptoragonisten | |
| UA85505C2 (en) | Kinase inhibitors | |
| MY133335A (en) | Photoresist compositions | |
| TW200639283A (en) | Elastic fibers having reduced coefficient of friction | |
| WO2009114856A3 (en) | Aurora kinase inhibitors | |
| TW200745187A (en) | Protecting agent | |
| WO2005048999A3 (en) | Use of cyclooxygenase-2 inhibitors for the treatment of depressive disorders | |
| TN2009000008A1 (en) | Pharmaceutical composition containing saredutant and a selective inhibitor of serotonin recapture or an inhibitor of serotonin/norepinephrine recapture in combination | |
| GB0422152D0 (en) | Containers for the distribution of chemicals | |
| TW200615292A (en) | Additives for epoxy resins | |
| TW505072U (en) | Guiding auxiliary device for latent arc-welding | |
| TH74483A (th) | ตัวปรับของแอนโดรเจนรีเซพเตอร์ | |
| ITRM20040160A1 (it) | Procedimento e dispositivo di applicazione di un rivestimento anticorrosione. | |
| TW200706179A (en) | A composition for immunosuppression |